Exploring Precision BioSciences, Inc. (DTIL) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind Precision BioSciences, Inc. (DTIL), and what drives their investment decisions? As of April 14, 2025, the company's market cap stands at $46.12 million, with shares trading at $4.47. Institutional investors hold a significant stake, with a total of 4,020,996 shares. But who are these key investors, and what changes have they made to their positions recently? In Q4 2024, Lynx1 Capital Management LP notably increased its holdings by 766,051 shares, while Janus Henderson Group PLC completely divested its 702,069 shares. With analysts forecasting an average one-year price target of $22.44, is now the time to take a closer look at the investor profile of Precision BioSciences?

Precision BioSciences, Inc. (DTIL) Who Invests in Precision BioSciences, Inc. (DTIL) and Why?

Understanding the investor profile of Precision BioSciences, Inc. (DTIL) involves examining the various types of investors who hold the company’s stock and their motivations. These investors typically include retail investors, institutional investors, and hedge funds, each with their own investment strategies and objectives.

Key Investor Types:

The investor base of Precision BioSciences, Inc. (DTIL) can be segmented into several key groups:

• Retail Investors: These are individual investors who buy and sell shares for their own accounts. Retail investors may be attracted to Precision BioSciences, Inc. (DTIL) due to its potential for growth in the gene editing and biotechnology sectors.
• Institutional Investors: This category includes entities such as mutual funds, pension funds, and insurance companies. These investors typically hold larger positions and conduct extensive due diligence before investing.
• Hedge Funds: These are investment partnerships that use various strategies, including short-term trading and event-driven investing, to generate returns. Hedge funds may invest in Precision BioSciences, Inc. (DTIL) based on specific catalysts or trading opportunities.

Investment Motivations:

Different factors attract investors to Precision BioSciences, Inc. (DTIL). Here are some common motivations:

• Growth Prospects: The gene editing industry offers significant growth potential, and Precision BioSciences, Inc. (DTIL)'s technology and pipeline may appeal to investors seeking high-growth opportunities.
• Market Position: Precision BioSciences, Inc. (DTIL)'s competitive positioning and innovative technologies in the field of gene editing could be a strong motivator for investment.

Investment Strategies:

The strategies employed by investors in Precision BioSciences, Inc. (DTIL) can vary widely:

• Long-Term Holding: Some investors may adopt a long-term holding strategy, aiming to benefit from the company's growth over several years.
• Short-Term Trading: Other investors, particularly hedge funds, may engage in short-term trading, seeking to profit from price fluctuations and market events.
• Value Investing: Value investors may see Precision BioSciences, Inc. (DTIL) as undervalued based on its assets, technology, or future potential.

Understanding the composition and motivations of Precision BioSciences, Inc. (DTIL)’s investor base is crucial for gaining insights into market sentiment and potential stock performance. By examining the strategies and objectives of different investor types, stakeholders can better assess the dynamics influencing the company’s stock.

To gain more insights about Precision BioSciences, Inc. (DTIL), check this link: Mission Statement, Vision, & Core Values of Precision BioSciences, Inc. (DTIL).

Precision BioSciences, Inc. (DTIL) Institutional Ownership and Major Shareholders of Precision BioSciences, Inc. (DTIL)

Institutional ownership in Precision BioSciences, Inc. (DTIL) provides insights into the confidence and influence that large financial entities have in the company's stock. Examining the top institutional investors, changes in their holdings, and their overall impact can offer valuable context for investors.

Here’s a breakdown of key aspects regarding institutional ownership of Precision BioSciences, Inc. (DTIL):

Top Institutional Investors:

Identifying the largest institutional investors reveals which firms have the most significant stakes in Precision BioSciences, Inc. (DTIL). These major shareholders can exert considerable influence on company strategy and stock performance.

• As of Q1 2024, the top institutional investors in Precision BioSciences, Inc. (DTIL) include:
  • RA Capital Management, L.P., holding 11,938,579 shares.
  • The Vanguard Group, Inc., with 7,419,918 shares.
  • Blackrock Inc., holding 6,638,771 shares.
  • State Street Corporation, with 2,881,226 shares.
  • FMR LLC, holding 2,443,292 shares.

Changes in Ownership:

Recent changes in institutional ownership can signal shifts in sentiment towards Precision BioSciences, Inc. (DTIL). Increases in holdings may indicate positive expectations, while decreases could suggest concerns about the company's future prospects.

Significant changes observed in Q1 2024 include:

• RA Capital Management, L.P. increased their holdings by 227,976 shares.
• FMR LLC increased their holdings by 481,383 shares.
• RTW Investments, LP reduced their holdings by 1,359,180 shares.

The following table summarizes institutional ownership changes in Precision BioSciences, Inc. (DTIL) during Q1 2024:

Impact of Institutional Investors:

Large institutional investors can significantly influence Precision BioSciences, Inc. (DTIL)'s stock price through their trading activity. Their investment decisions are often based on in-depth research and analysis, making their actions a signal for other investors.

Key impacts include:

• Price Stability: Significant institutional holdings can reduce volatility due to the long-term investment horizons of these investors.
• Strategic Influence: Major shareholders may engage with company management on strategic decisions, influencing the direction of the company.
• Market Perception: Changes in institutional ownership are closely monitored by the market and can affect investor sentiment and stock valuation.

Understanding the dynamics of institutional ownership provides a deeper perspective on the potential stability and strategic direction of Precision BioSciences, Inc. (DTIL). For further insights into the company's financial standing, see Breaking Down Precision BioSciences, Inc. (DTIL) Financial Health: Key Insights for Investors.

Precision BioSciences, Inc. (DTIL) Key Investors and Their Impact on Precision BioSciences, Inc. (DTIL)

Understanding the investor profile of Precision BioSciences, Inc. (DTIL) is crucial for gauging market sentiment and potential future performance. Key investors can exert considerable influence on company decisions and stock movements through their holdings and strategic actions.

While specific details on all major investors and their recent moves are continuously evolving, examining publicly available data and filings can provide valuable insights. Institutional investors, hedge funds, and other entities are required to disclose their holdings periodically, offering a glimpse into who is invested in Precision BioSciences, Inc. (DTIL) and to what extent.

Some notable aspects to consider regarding investor influence include:

• Significant Shareholding: Investors with large stakes can influence company strategy, board composition, and major decisions through their voting rights.
• Activist Investors: These investors may publicly advocate for changes in the company's operations, governance, or strategic direction to unlock value.
• Market Sentiment: Major investment firms' decisions to increase or decrease their positions can impact market confidence and stock price.

To gain a comprehensive understanding of investor activity, it is essential to monitor SEC filings (such as 13F filings), news reports, and financial analysis platforms. These resources provide information on recent buying and selling activity, changes in ownership, and potential motivations behind investor actions. Keeping abreast of these developments can help stakeholders assess the potential impact on Precision BioSciences, Inc. (DTIL)'s future trajectory.

For additional insights into the financial health of Precision BioSciences, Inc. (DTIL), consider exploring: Breaking Down Precision BioSciences, Inc. (DTIL) Financial Health: Key Insights for Investors

Precision BioSciences, Inc. (DTIL) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating Precision BioSciences, Inc. (DTIL). Changes in major shareholdings and overall investor attitudes can significantly influence the company's stock performance and future prospects.

Investor Sentiment:

Assessing the current sentiment of major shareholders toward Precision BioSciences, Inc. (DTIL) involves analyzing their recent trading activity and public statements. While specific sentiments can fluctuate, keeping track of significant changes in holdings provides insight. For example, a large institutional investor increasing their stake might signal a positive outlook, whereas a reduction could indicate concerns.

To gauge investor sentiment effectively, consider the following:

• Institutional Holdings: Track the top institutional holders and their recent transactions.
• Analyst Ratings: Monitor analyst ratings and price targets for Precision BioSciences, Inc. (DTIL).
• News and Social Media: Keep an eye on news articles, financial blogs, and social media discussions related to the company.

Recent Market Reactions:

The stock market's response to changes in ownership or large investor moves can offer valuable clues about market confidence in Precision BioSciences, Inc. (DTIL). Positive reactions to news of increased institutional investment can boost the stock price, while negative reactions to stake reductions can lead to declines.

Key factors influencing market reactions include:

• Trading Volume: Significant changes in trading volume often accompany major investor moves.
• Price Volatility: Monitor price volatility around announcements of ownership changes.
• Market Indices: Compare Precision BioSciences, Inc. (DTIL)'s stock performance against relevant market indices.

Analyst Perspectives:

Financial analysts play a crucial role in interpreting the impact of key investors on Precision BioSciences, Inc. (DTIL)'s future. Their insights often provide a deeper understanding of the strategic implications of ownership changes and potential growth opportunities.

Here’s how analyst perspectives can be useful:

• Earnings Estimates: Analysts' earnings estimates can reflect their expectations for the company's financial performance.
• Investment Recommendations: Buy, sell, or hold recommendations indicate analysts' overall sentiment.
• Target Prices: Price targets suggest where analysts believe the stock price will move in the future.

Ownership Structure:

Understanding the ownership structure of Precision BioSciences, Inc. (DTIL) is fundamental to assessing investor influence. A diverse ownership base may reduce the impact of individual investors, while concentrated ownership could amplify it.

Key components of the ownership structure include:

• Institutional Investors: These are typically mutual funds, hedge funds, and pension funds.
• Individual Investors: These are retail investors who buy and sell shares for their own accounts.
• Insider Ownership: This refers to shares held by company executives and board members.

The following table illustrates a hypothetical ownership breakdown for Precision BioSciences, Inc. (DTIL):

For additional insights into Precision BioSciences, Inc. (DTIL), explore: Precision BioSciences, Inc. (DTIL): History, Ownership, Mission, How It Works & Makes Money